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Summaiy: Administration of ambilhar or its N-acetyl derivative to rabbits resulted in a significant increase in urinary
iron excretion, due to chelation. Substitution of the sulphur of thiazole by nitrogen abolished its metal chelating
power.
In vitro three different iron chelates were obtained, containing one or two iron atoms per mole of drug. However, in
vivo studies revealed the presence of an ambilhar iron complex in which 6 molecules of the drug were chelated with
one iron atom. Reduction is an important factor in the process of metal chelation by the thiazole sulphur of the
drag.
Rolle des Thiazolyl-Schwefels von Ambilhar als Elektronendonator bei der Metall-Chelat-Bildung
Zusammenfassung: Applikation von Ambilhar oder seines N-Acetylderivats bei Kaninchen führte zu einem signifikan-
ten Anstieg der Ausscheidung von Eisen im Harn aufgrund von Chelatbildung. Substitution des Thiazolyl-Schwefels
durch Stickstoff verstärkte die Chelatbildung. In vitro wurden drei verschiedene Eisenchelate, die ein oder zwei Atome
Eisen enthielten, gefunden. In vivo wurde jedoch die Anwesenheit eines Chelats beobachtet, wobei sechs Moleküle
ein Atom Eisen gebunden enthielten. Reduktion ist ein wichtiger Faktor im Prozeß der Metall-Chelat-Bildung durch
Thiazolyl-Schwefel von Ambilhar.
introduction
Ambilhar, niridazole or nitrothiazole is a selective drug
for schistosomiasis (1). Administration of the drag to
normal rats caused a significant decrease in the iron
content of liver and serum, with an accompanying
increase in urinary iron excretion (2,3), which was
explained on the basis of metal chelation by the drug
(4). Later on it was reported that ambilhar depleted
calciutn and magnesium in blood and tissues as a result
of chelation (5). The same authors also demonstrated
chelation by the drug in vitro.
Further studies on the active chelating centre in the
drug molecule were not performed. Furthermore, little
or no work on the factors affecting the chelating power
of the drug with cations has been reported. It could
therefore be of clinical rather than toxicological value
to study the effect of some ambilhar derivatives on metal
chelation in vivo as well as in vitro.
Materials and Methods
24 normal rabbits (Lepus caniculus), average body weight 1.5 kg,
were used. The animals were divided into four equal groups.
Their diet consisted of normal greens (alfa alfa) growing in the
area of Ninava in North of Iraq. Animals of groups 1, 2 and 3
were dosed with ambilhar, acetyl ambilhar and a sulphur sub-
stituted derivative respectively. Those of group 4 were used as
control.
Ambilhar (Analar grade) was obtained from Ciba-Geigy research
Laboratories. The N-acetyl derivative was prepared in our
laboratories by treating a known weight of the drug with acetic
anhydride for 24 hours. After crystallisation from hot water
yellowish white crystals of m.p. 175 °C were obtained.
The nitrogen-substituted derivative was prepared by mixing
two g ambilhar, 3 g ammonium acetate and 20 ml glacial acetic
acid. The whole mixture was refluxed for 6 hours. The compound
went into a dark brown solution and H2S gas was evolved. The
mixture was filtered and allowed to cool, and a brown crystalline
compound was precipitated. This was crystallised from methanol
to give yellow crystals of m.p. 240 °C (dec.).
Urinary iron estimation
Total urine of each group of animals was collected daily and
separately. The iron content of each group was quantitated after
ashing 25 ml of urine, and dissolving the ash in 5 ml of 5 mol/1
HC1, according to the method described by Ramsay (6).
Iron ambilhar chelates in vitro
To one gram pure crystalline ambilhar, two grams sodium meta-
bisulphite and 100 mg reduced iron metal (British Drug Houses)
were added. The whole mixture was pulverised in a glass mortar,
and added slowly to 50 ml distilled water in a beaker. The mix-
ture was boiled for a few minutes on a gentle direct flame, until
it became a dark brown clear solution. After filtration and slow
cooling» a dark crystalline compound was precipitated (complex
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1), which was recrystallized from glacial acetic acid. This com-
pound was decomposed by heat, leaving a metallic residue. The
filtrate was concentrated on a boiling water bath to half its
volume, and left to cool gradually; a brown coloured substance
(complex 2) separated. This was filtered, washed with 700 g/i
alcohol and distilled water, then crystallised from hot glacial
acetic acid. It was decomposed by heat leaving a metallic residue.
The filtrate was concentrated to one half its volume and left to
cool, whereupon a brownish yellow compound (complex 3)
separated. This was filtered, washed with alcohol and distilled
water, then crystallised from glacial acetic acid. It was deconr-
posed by heat leaving a metallic residue. The purity of the
prepared complexes was tested by paper Chromatographie studies
using Whatman No. 1 filter paper; and Ë-butanol, glacial acetic
acid and water (20 ml + 20 ml + 10 ml) respectively in an
ascending system. All the three iron complexes ran as single
spots. Fifty mg samples of each complex were sent for micro-
analysis to Alfred Bernhardt (W. Germany).
Ultra violet spectra of drugs and their iron complexes
Ultra violet spectra of ambilhar, its nitrogen-substituted deriva-
tive and the laboratory-synthesized iron drug complexes 1, 2 and
3 were recorded with the aid of a Sp. 1800 spectrophotometer.













Spectra: Infra red (Nujol) 3200-3250 cm"1 (NH)
1685 cm"1 (CO)
NMR study: 6(C5DSN): 8.4 (s, olefinic hydrogen)
9.07 (s, exchangable, NH of imidazole)




Table 1 shows the effect of ambilhar, N-acetyl-ambilhar
and its nitrogen-substituted derivative on urinary iron
output. Ambilhar and its N-acetyl derivative caused a
significant increase in the excretion of iron, whereas the
nitrogen-substituted derivative showed little effect on
urinary iron output.
Table 2 shows the iron percentage as well as the chela-
tion ratios between the drug and iron in vitro. The per-
centage of iron in the complexes (1,2,3) were found to
be 44.2%, 22.27% and 10.07% respectively. This repre-
sents the chelation ratios of one mole of the drug with
two iron atoms (complex 1), one mole of drug with one
iron atom (complex 2) and two moles of the drug with
one iron atom (complex 3) respectively.
Figure 1 demonstrates the effect of sodium metabi-
sulphite on the spectrum of ambilhar. In the presence of
this reducing agent, the major peak at 375 nm disap-
peared, while another peak at 240 nm appeared. After
adding iron, the peak at 240 nm largely disappeared.
The preparation of this compound was a modification of the
method reported by El-Kholy et al. (7), in which oxygen was
replaced by nitrogen inside the heterocyclic ring.
Tab. 1. Effect of ambilhar, N-acetyl-ambilhar and its nitrogen-
substituted derivative on urinary iron output in rabbits,
(mg iron/day).
Drug Iron excretion
(mg/d) ÷ ± SD































2) Significant at 1% level of probability
Tab. 2. Iron content (%) of the in vitro prepared iron ambilhar
complexes. (Alfred Bernhardt laboratories).

















1. Effect of reducing agents as well as iron chelation on the
ultra violet spectrum of amt>ilhar ( ). In the presence
of sodium metabisulphite ( ), the peak at 375 nm
disappeared, while a new peak at 240 nm appeared. After
subsequent chelation with iron ( ) disappearance of
these two peaks was observed.
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Behaviour of the thiazole peak at 375 nm in metal chela-
tion is also shown. Disappearance of this peak was also
observed on reduction.
Figure 2 shows the ultra violet spectra of ambilhar and
its nitrogen analogue. Disappearance of the major peak
at 375 nm after substitution of sulphur by nitrogen was
observed. This indicates the importance of sulphur in
metal chelation, and suggests that peak at 375 nm is








Fig. 2. Ultra violet spectra of ambilhar ( ) and its nitrogen
analogue in the presence of iron ( ) and in the absence
of iron ( ). Addition of iron did not produce any
change in the spectrum of the nitrogen-substituted deriva-
tive. On the other hand substitution of sulphur by nitro-
gen resulted in disappearance of the peak at 375-380 nm
in ambilhar.
Discussion
It is clear from table 1 that substitution of thiazolyl
sulphur of ambilhar by nitrogen resulted in a significant
decrease in the ability of the drug to increase urinary
iron output. Such an observation could be important
evidence for the role of thiazole sulphur in the chelation
of iron and possibly other metals (5).
The ultra violet spectra of ambilhar and its nitrogen
analogue suggest that the thiazole ring and more
specifically its sulphur could be responsible for the
major peak at 375 nm which disappeared after metal
chelation or substitution by nitrogen (fig. 1,2). Also,
reduction of the drug is essential for chelation with iron
in vitro, forming three different chelates. This is further
supported by the findings of Feller et al. (8) m& Morita
et al. (9) that niridazole or ambilhar is reduced in vivo
by liver microsomes and subsequently by rat liver
xanthine oxidase.
In vitro, the drug formed three different chelates with
iron. In our view the isolation of ambilhar iron chelates
with lesser amounts of iron (complexes 2, 3) is probably
due to incomplete reaction in vitro.
However, in vivo, one atom of iron chelated with
6 molecules of the drug (4), which is probably due to the
lower concentration of the metal in liver.
Finally the presence and wide distribution of iron
sulphur complexes in animal and plant tissues support
our view of the involvement of thiazolyl sulphur in the
process of iron chelation (10, 11).
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